ERBB2 and cancer: This immune protection is much more difficult to achieve in cancer-prone BALB-neuT mice, which are tolerant to rat HER2 protein because they express the transgene protein product in their thymus early in life, and for this reason they completely lack T cells that recognize dominant epitopes with high affinity (Rolla et al., 2006, 2010).